To implement the recommended practice under The UK Corporate Governance Code, the Audit Committee (the "Audit Committee") of Hutchison China MediTech Limited (the "Company") has recommended and the Board of Directors of the Company (the "Board") has adopted these procedures (the "Procedures") to ensure that complaints and concerns expressed by officers and employees (collectively, the "Employees") of the Company, its subsidiaries and affiliated businesses (the "Group") regarding the business and operations of the Group are heard and addressed appropriately.
The purpose of these Procedures is to establish procedures for the confidential receipt, retention, and treatment of complaints from, or concerns raised by, Employees regarding accounting, internal accounting controls and auditing matters as well as illegal or unethical matters.
All existing Employees are, and all new Employees at the time they join the Group will be, notified of the Procedures.
These Procedures will be reviewed by the Audit Committee from time to time as warranted to ensure their continuing compliance with applicable laws and listing standards (if any) as well as their effectiveness.
All amendments to these Procedures must be endorsed by the Audit Committee and adopted by the Board.
The following sets forth the mechanism to be put in place for: (i) Employees to make complaints or raise concerns to the Company, and (ii) the Company to address complaints received.
At each Audit Committee meeting or such other times as Audit Committee requires, the General Manager of GMS will report to the Audit Committee with respect to complaints received since the immediately prior status report, the status of all investigations pending and the resolution and outcome of all investigations that have been terminated or completed since the immediately prior status report. A copy of each status report will also be provided to the Chairman, CEO and the Company Secretary.
All reports are confidential. The identity of the Reporter will not be divulged save with such Reporter's consent or where:
These Procedures shall be read in conjunction with and subject to any relevant laws, regulations, rules, directives or guidelines that the AIM market of the London Stock Exchange, the NASDAQ Stock Market or any other regulatory bodies may from time to time prescribe or issue on the matters governed by these Procedures.
In the event that any Procedures herein are inconsistent or in conflict with any relevant laws, regulations, rules, directives or guidelines as prescribed by the AIM market of the London Stock Exchange, the NASDAQ Stock Market or any other regulatory bodies or any part thereof, the latter shall prevail to the extent of such inconsistency or conflict.
Updated as of 17 March 2016